Work

CHK1 and CHK2 as Context-Dependent Rheostats of Genotoxic Stress: Implications for Cell Fate and Tumor Immunity

Year: 2026

Type: review

Abstract: The DNA damage response (DDR) is a central determinant of tumor cell fate and therapeutic response. Checkpoint kinase 1 (CHK1) and checkpoint kinase 2 (CHK2) are canonical mediators of DDR, traditionally viewed as regulators of cell-cycle arrest and genome stability. Emerging evidence reveals broader roles in coordinating cell fate decisions and tumor-immune interactions. However, how checkpoint signaling translates genotoxic stress into divergent cell fate and immune outcomes remains unresolved. Here, we synthesize current evidence to propose a graded rheostat framework in which CHK1 and CHK2 integrate genotoxic stress signals to regulate diverse cell-fate and immune outputs. Although CHK1 and CHK2 share partially overlapping functions, current evidence suggests that CHK1 often contributes to stress-adaptive buffering, whereas CHK2 is more frequently implicated in damage-associated apoptotic commitment; however, these functional tendencies vary with p53 status, tumor lineage, damage characteristics including intensity and duration, treatment context, and cellular state. These distinct yet interconnected roles may be associated with emerging non-canonical programmed cell death pathways beyond canonical apoptosis, although current evidence remains limited and context-dependent. Importantly, CHK1/CHK2 signaling also shapes the tumor immune microenvironment (TIME) by regulating cytosolic DNA accumulation, cGAS-STING activation, antigen presentation, and immune checkpoint regulation. This suggests a mechanistic interface between genomic instability and anti-tumor immunity. Together, this review provides a mechanistic and translational perspective on how DDR signaling governs cell fate and immune outcomes, thereby providing a rationale for biomarker-guided combination strategies.

Source: International Journal of Biological Sciences

DOI: 10.7150/ijbs.139580